Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BTM 1086

Known as: BTM-1086 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryAn attempt was made to characterize the muscarine receptor type(s) involved in acid secretion in the mouse isolated… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
1990
1990
The potency and selectivity of (-)cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5 benzothiazepin-4-(5H)one HCl (BTM… Expand
1989
1989
The affinities of the (+) and (-) enantiomers of the antimuscarinic benzothiazepinone derivative, cis-2,3-dihydro-3-(4-methyl-1… Expand
1987
1987
Selectivity of cis(-)-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-b enzothiazepin-4 (5H)-one monohydrochloride (BTM… Expand
1986
1986
Effects of (-) cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-benz othiazepin-4-(5H ) -one hydrochloride (BTM-1086… Expand
1986
1986
Anti-ulcerous and anti-secretory effects of (-)-cis-2, 3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1, 5-benzothiazepin-4-(5H… Expand
1986
1986
An enzyme immunoassay for an anti-ulcer agent, (-)-cis-2, 3-dihydro-3-(4-methylpiperazinyl-metyl)2-phenyl-1, 5-benzothiazepin-4… Expand
1983
1983
(-)-cis-2, 3-Dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1, 5-benzothiazepin-4 (5H)-one hydrochloride (BTM-1086) and its… Expand